Literature DB >> 17041757

Apoptosis promoted by up-regulation of TFPT (TCF3 fusion partner) appears p53 independent, cell type restricted and cell density influenced.

Chiara Franchini1, Floriana Fontana, Mario Minuzzo, Federica Babbio, Enrica Privitera.   

Abstract

The TFPT/FB1 gene was identified because of its involvement in childhood pre-B acute lymphoblastic leukaemia (ALL). Although its specific function is still unclear, Tfpt has been implicated in cell proliferation and induction of programmed cell death (PCD). Given the critical role of PCD in leukemogenesis, we have investigated the responsiveness of different cell lines to TFPT over expression and the consequent induction of PCD by proliferation kinetic analysis, immunolocalization and TUNEL assay. We have also tested the involvement of factors implicated in cell cycle progression and apoptosis, i.e. caspases, p53, Cdc2. Our results indicate that over expression of TFPT promotes caspase 9-dependent apoptosis, nevertheless the apoptotic cascade is engaged only in culture conditions sustaining cell proliferation and different cell lines display differential responsiveness to TFPT induced apoptosis Although p53 is a main regulator of apoptosis in mammalian cells, the Tfpt induced apoptosis appears p53-independent. These results are discussed relatively to the role played by TFPT in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041757     DOI: 10.1007/s10495-006-0195-5

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  5 in total

1.  Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Authors:  Brett M Reid; Jennifer B Permuth; Y Ann Chen; Brooke L Fridley; Edwin S Iversen; Zhihua Chen; Heather Jim; Robert A Vierkant; Julie M Cunningham; Jill S Barnholtz-Sloan; Steven Narod; Harvey Risch; Joellen M Schildkraut; Ellen L Goode; Alvaro N Monteiro; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-04-04       Impact factor: 4.254

2.  Determining frequent patterns of copy number alterations in cancer.

Authors:  Franck Rapaport; Christina Leslie
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

3.  Pooled-matrix protein interaction screens using Barcode Fusion Genetics.

Authors:  Nozomu Yachie; Evangelia Petsalaki; Joseph C Mellor; Jochen Weile; Yves Jacob; Marta Verby; Sedide B Ozturk; Siyang Li; Atina G Cote; Roberto Mosca; Jennifer J Knapp; Minjeong Ko; Analyn Yu; Marinella Gebbia; Nidhi Sahni; Song Yi; Tanya Tyagi; Dayag Sheykhkarimli; Jonathan F Roth; Cassandra Wong; Louai Musa; Jamie Snider; Yi-Chun Liu; Haiyuan Yu; Pascal Braun; Igor Stagljar; Tong Hao; Michael A Calderwood; Laurence Pelletier; Patrick Aloy; David E Hill; Marc Vidal; Frederick P Roth
Journal:  Mol Syst Biol       Date:  2016-04-22       Impact factor: 11.429

4.  The origins and genetic interactions of KRAS mutations are allele- and tissue-specific.

Authors:  Joshua H Cook; Giorgio E M Melloni; Doga C Gulhan; Peter J Park; Kevin M Haigis
Journal:  Nat Commun       Date:  2021-03-22       Impact factor: 14.919

5.  Heterozygous deletions of noncoding parts of the PRPF31 gene cause retinitis pigmentosa via reduced gene expression.

Authors:  Francesco Paolo Ruberto; Sara Balzano; Prasanthi Namburi; Adva Kimchi; Rosanna Pescini-Gobert; Alexey Obolensky; Eyal Banin; Tamar Ben-Yosef; Dror Sharon; Carlo Rivolta
Journal:  Mol Vis       Date:  2021-03-18       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.